Lab21

About:

Lab21 is a rapidly growing healthcare diagnostics business. The company’s vision is of providing personalised diagnostic testing for

Website: http://lab21.com

Twitter/X: lab21cambridge

Top Investors: Clydesdale Bank, Medicis Capital

Description:

Lab21 is a rapidly growing healthcare diagnostics business. The company’s vision is of providing personalised diagnostic testing for disease identification, disease predisposition and personalised medicine to protect people from the health problems of tomorrow. We believe that ‘prevention is better than cure’ and aim to provide information that helps to protect people from their health problems of tomorrow.Lab 21 Clinical Laboratory supports healthcare providers and the pharmaceutical and biotechnology industries with technically advanced testing services from its accredited facilities in Cambridge, UK. The Lab 21 team’s experience and know-how is coupled with a rapidly growing portfolio of molecular and viral diagnostics, plus next generation sequencing, pharmacogenetic and patient profiling tests, which all use cutting-edge technology. This unique combination adds value to pharmaceutical, diagnostic and biotech partners – and directly to clinicians or healthcare providers as they treat and monitor their patients.As we move towards truly personalised healthcare, the Lab 21 team contributes today – delivering high-quality information on drugs and patients that provides real clinical insight.

Total Funding Amount:

$13.6M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2005-01-01

Contact Email:

info(AT)lab21.com

Founders:

Berwyn Clarke

Number of Employees:

51-100

Last Funding Date:

2012-08-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai